BAMCO Inc

BAMCO Inc’s Moderna MRNA Stock Holding History

BAMCO Inc’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,500	Closed	-$746K	–	339
2023 Q4	$746K	Sell	7,500 -419,369	-98%	-$35.3M	﹤0.01%	307
2023 Q3	$44.1M	Buy	426,869 +418,269	+4,864%	+$46.7M	0.13%	130
2023 Q2	$1.04M	Sell	8,600 -4,900	-36%	-$654K	﹤0.01%	307
2023 Q1	$2.07M	Sell	13,500 -16,500	-55%	-$2.72M	0.01%	298
2022 Q4	$5.39M	Buy	30,000 +13,000	+76%	+$2.13M	0.02%	266
2022 Q3	$2.01M	Buy	17,000 +5,300	+45%	+$804K	0.01%	309
2022 Q2	$1.67M	Buy	+11,700	New	+$1.67M	0.01%	329
2022 Q1	–	Sell	-2,532	Closed	-$643K	–	407
2021 Q4	$643K	Sell	2,532 -46,800	-95%	-$13.7M	﹤0.01%	382
2021 Q3	$19M	Sell	49,332 -15,950	-24%	-$5.88M	0.04%	260
2021 Q2	$15.3M	Buy	65,282 +21,100	+48%	+$3.77M	0.04%	273
2021 Q1	$5.79M	Buy	44,182 +40,382	+1,063%	+$5.85M	0.01%	314
2020 Q4	$397K	Buy	+3,800	New	+$384K	﹤0.01%	351
2020 Q3	–	Sell	-1,000	Closed	-$64K	–	367
2020 Q2	$64K	Buy	+1,000	New	+$54.8K	﹤0.01%	327

Other funds holding MRNA

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return